Inventor
WEI GE
US26 patents
⚠️ This page may combine multiple inventors who share the name “WEI GE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HALOZYME INC
19 patentsUS11066656B2Jul 20, 2021
PH20 polypeptide variants, formulations and uses thereof
HALOZYME INC30 citations98
US11041149B2Jun 22, 2021
PH20 polypeptide variants, formulations and uses thereof
HALOZYME INC32 citations98
US10865400B2Dec 15, 2020
PH20 polypeptide variants, formulations and uses thereof
HALOZYME INC25 citations98
US12091692B2Sep 17, 2024
PH20 polypeptide variants, formulations and uses thereof
HALOZYME INC3 citations86
US12104185B2Oct 1, 2024
PH20 polypeptide variants, formulations and uses thereof
HALOZYME INC2 citations84
US11952600B2Apr 9, 2024
PH20 polypeptide variants, formulations and uses thereof
HALOZYME INC2 citations84
US12371685B2Jul 29, 2025
PH20 polypeptide variants with a modification at position 324 of the PH20 polypeptide and a method of making thereof
HALOZYME INC0 citations73
US12264345B1Apr 1, 2025
PH20 polypeptide variants, formulations and uses thereof
HALOZYME INC0 citations73
US12195773B2Jan 14, 2025
PH20 polypeptide variants, formulations and uses thereof
HALOZYME INC0 citations73
US12152262B2Nov 26, 2024
PH20 polypeptide variants, formulations and uses thereof
HALOZYME INC0 citations73
US12123035B2Oct 22, 2024
PH20 polypeptide variants, formulations and uses thereof
HALOZYME INC0 citations73
US12110520B2Oct 8, 2024
PH20 polypeptide variants, formulations and uses thereof
HALOZYME INC0 citations73
US12104184B2Oct 1, 2024
PH20 polypeptide variants, formulations and uses thereof
HALOZYME INC0 citations73
US12077791B2Sep 3, 2024
PH20 polypeptide variants with a modification at position 309 of the PH20 polypeptide and a method of making thereof
HALOZYME INC1 citations73
US12060590B2Aug 13, 2024
PH20 polypeptide variants, formulations and uses thereof
HALOZYME INC0 citations73
US12054758B2Aug 6, 2024
PH20 polypeptide variants, formulations and uses thereof
HALOZYME INC0 citations73
US12049652B2Jul 30, 2024
PH20 polypeptide variants, formulations and uses thereof
HALOZYME INC0 citations73
US12037618B2Jul 16, 2024
PH20 polypeptide variants, formulations and uses thereof
HALOZYME INC1 citations73
US12018298B2Jun 25, 2024
PH20 polypeptide variants, formulations and uses thereof
HALOZYME INC1 citations73
WEI GE
3 patentsUS9447401B2Sep 20, 2016
PH20 polypeptide variants, formulations and uses thereof
WEI GE47 citations98
US9284543B2Mar 15, 2016
Neutral active soluble truncated PH20 polypeptides and uses thereof
WEI GE39 citations91
US8927249B2Jan 6, 2015
Extended soluble PH20 polypeptides and uses thereof
WEI GE26 citations90